Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan"
Buenos Aires, C1245AAM, Argentina
Location status: Recruiting
Location contact
Maria T Mazzucchelli
CONTACT
Mariela Jozefkowicz
CONTACT
NCT Number: NCT06408376
Congenital diaphragmatic hernia (CDH) is a malformation that affects 1 in every 3000 newborns. The diaphragm does not complete its closure during embryogenesis, which allows the abdominal organs to herniate into the thoracic cavity altering lung development. The lungs of patients with CDH are small, with a decreased surface area for gas exchange and developmental impair of the pulmonary vasculature, resulting in respiratory failure and pulmonary hypertension shortly after birth. When clamping the umbilical cord, a large part of the preload is abruptly excluded, generating an increase in vascular resistance, which in turn increase the afterload, resulting in a decrease in cardiac output. The output is restored by decreasing vascular resistance in pulmonary circuit after lung aeration upon receiving the preload of the right atrium, increasing pulmonary flow and thus sustaining the preload of the left ventricle. If pulmonary aeration occurs before clamping the umbilical cord, the pulmonary blood flow increases before placenta flow is lost, thus avoiding a decrease in cardiac output. This modality has been called physiological base cord clamping (PFC). The hypothesis is that PFC once ventilation has been established could prevent hypoxia and improve cardiac output in newborns with CDH and secondarily improve their hemodynamic parameters, stabilizing gas exchange and pulmonary hypertension during the first 24 hours of birth.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Buenos Aires, C1245AAM, Argentina
Location status: Recruiting
Maria T Mazzucchelli
CONTACT
Mariela Jozefkowicz
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Immediately after birth, the newborn with prenatal diagnosis of CDH will be placed on a mobile table, made to receive these patients in the delivery room, at the level of the mother's womb, leaving the umbilical cord intact and intubated. The patient will be gently ventilated (PIM 15/25 - PEEP 4 - Fio2 50%), until saturation >85% and HR>100 or 10 timed minutes have elapsed, whichever occurs first, the umbilical cord will be clamped.
Time frame: 24 hours of life
Hemodynamic deterioration in the first 24 hours of life (meeting 3 of 4 of the following criteria or entry to extracorporeal membrane oxygenation (ECMO) or Death).
Time frame: delivery
Complete the protocol in the delivery room pre-established according to randomization (yes/no)
Time frame: 1st day of life
Gestational age at diagnosis of CDH in weeks
Time frame: from 26 to 32 weeks of gestational age
lung heart rate index observed/expected (LHR O/E)
Time frame: from 26 to 32 weeks of gestational age
liver in thorax (yes/no) and %
Time frame: from 26 to 32 weeks of gestational age
stomach herniation (yes/no) and %
Time frame: from 26 to 32 weeks of gestational age
lung volumen in RMI
Time frame: from 26 to 32 weeks of gestational age
Mcgoon Index in fetal echocardiogram
Time frame: 1 day before delivery
maternal hematocrit in gr/dl
Time frame: From delivery to intubation
Time to intubation (minutes, seconds)
Time frame: from delivery to cord clamping
Cord clamping time (minutes, seconds)
Time frame: from delivery to 30 minutes of life
Requirement for advanced resuscitation (yes/no) (compressions, drugs, hypothermia)
Time frame: from delivery to 30 minutes of life
Time to reach HR >100 (minutes, seconds)
Time frame: from delivery to 30 minutes of life
Time to reach SAT >85% (minutes, seconds)
Time frame: inmediatly after cord clampping
cord ph value
Time frame: inmediatly after cord clampping
cord lactic acid value in mmol/l
Time frame: 10 minutes of life
pre and post ductal saturation %
Time frame: 10 minutes of life
mean arterial tension in mmhg
Time frame: 30 minutes of life
Time for placental abruption (minutes, seconds)
Time frame: 10 minutes after delivery
mothers arterial mean tension after delivery in mmhg
Time frame: 30 minutes after delivery
uterotonics use on mothers after delivery (yes/no)
Time frame: 2 - 4 hours and 24 hours of life
Blood pressure in mmhg
Time frame: 2 - 4 hours and 24 hours of life
Inotrope requirement (yes/no)
Time frame: 2 - 4 hours and 24 hours of life
NOi requirement (yes/no)
Time frame: 2 - 4 hours and 24 hours of life
Ventilatory mode / mean airway pressure (MAP)/ FIo2 %
Time frame: 2 - 4 hours and 24 hours of life
Partial arterial pressure of oxygen (PaO2) mmhg
Time frame: 2 - 4 hours and 24 hours of life
OI
Time frame: 2 - 4 hours and 24 hours of life
Cerebral and somatic NIRS
Time frame: 24 hours of life
B natriuretic peptide (BNP)
Time frame: 6 and 24 hours of life
echocardiographic pulmonary hypertension PH (<50% of systemic pressure, between 50-80% of systemic pressure, between 80 and 100% of systemic pressure, systemic, suprasystemic)
Time frame: 6 hours of life
cardiac malformation (yes/no)
Time frame: through study completion, an average of 1 year
Mortality (yes/no)
Time frame: through study completion, an average of 1 year
Admission to ECMO after the first 24 hours (yes/no)
Time frame: through study completion, an average of 1 year
maternal age during pregnancy
Time frame: through study completion, an average of 1 year
maternal pathological history during pregnancy (yes/no)
Time frame: 30 minutes of life
Weight in grams
Time frame: 6 and 24 hours of life
Patent ductus arteriosus (PAD): size in milimeters
Time frame: 6 and 24 hours of life
Patent ductus arteriosus (PAD): gradient
Time frame: 6 and 24 hours of life
Patent ductus arteriosus (PAD): shunt direction
Time frame: 6 and 24 hours of life
Patent foramen ovale (PFO): shunt direction.
Time frame: 6 and 24 hours of life
Right ventricle (RV): RV diameter in milimeters
Time frame: 6 and 24 hours of life
Right ventricle (RV): TAPSE
Time frame: 6 and 24 hours of life
tricuspide insufitienty
Time frame: 6 and 24 hours of life
Right ventricle global disfuntion : no, mild, moderate or severe
Time frame: 6 and 24 hours of life
Left ventricle (LV): eccentricity index
Time frame: 6 and 24 hours of life
Left ventricle (LV): ejection fraction (EF)
Time frame: 6 and 24 hours of life
Left ventricle (LV) global disfuntion : no, global disfuntion : no, mild, moderate or severe
Time frame: 6 and 24 hours of life
Interventricular septum: configuration
Time frame: 6 and 24 hours of life
Pulmonary hypertation: no, mild, moderate or severe
Time frame: 24 hours of life
Associated malformations (yes/no), which
Time frame: through study completion, an average of 1 year
Chromosomopathy or genetic alteration (yes/no), which
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Hyperbilirubinemia requiring phototherapy or exchange transfusion (yes/no)
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Early sepsis (yes/no)
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Omphalitis (yes/no)
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
CDH surgery (yes/no), days of life
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Surgical classification of CDH (a-b-c-d)
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Days in NICU
Contact information is provided by the study sponsor or research team.
Maria T Mazzucchelli
CONTACT
Mariela Jozefkowicz
CONTACT
Hospital JP Garrahan
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07385326
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04193345
Umbilical Cord Clamping
Cairo, Egypt
View Trial DetailsNCT06884423
Congenital Abnormalities, Congenital Diaphragmatic Hernia
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07577414
Congenital Abnormalities, Congenital Diaphragmatic Hernia
Ann Arbor, Michigan, United States
View Trial Details